Published in BMB Rep on December 01, 2012
A conserved motif in JNK/p38-specific MAPK phosphatases as a determinant for JNK1 recognition and inactivation. Nat Commun (2016) 0.77
Phosphorylation of Tip60 Tyrosine 327 by Abl Kinase Inhibits HAT Activity through Association with FE65. Open Biochem J (2013) 0.77
Phosphotyrosine Substrate Sequence Motifs for Dual Specificity Phosphatases. PLoS One (2015) 0.77
Crystal Structure of Human Myotubularin-Related Protein 1 Provides Insight into the Structural Basis of Substrate Specificity. PLoS One (2016) 0.75
Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell (2006) 20.92
Protein tyrosine phosphatases in the human genome. Cell (2004) 8.09
Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol (2006) 7.93
Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell (1999) 6.59
Crystal structure of human protein tyrosine phosphatase 1B. Science (1994) 4.95
A phosphatase associated with metastasis of colorectal cancer. Science (2001) 3.86
Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis. Nature (2003) 3.72
The structure and mechanism of protein phosphatases: insights into catalysis and regulation. Annu Rev Biophys Biomol Struct (1998) 3.64
Large-scale structural analysis of the classical human protein tyrosine phosphatome. Cell (2009) 3.51
Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol Cell Biol (2001) 3.37
Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science (1998) 3.10
PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci U S A (1998) 3.05
Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B. Science (1995) 3.02
Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development. Annu Rev Pharmacol Toxicol (2002) 2.63
Crystal structure of the dual specificity protein phosphatase VHR. Science (1996) 2.28
Eyes absent represents a class of protein tyrosine phosphatases. Nature (2003) 2.05
The transcription factor Eyes absent is a protein tyrosine phosphatase. Nature (2003) 2.04
Structural basis for inhibition of receptor protein-tyrosine phosphatase-alpha by dimerization. Nature (1996) 1.98
PRL-3 and PRL-1 promote cell migration, invasion, and metastasis. Cancer Res (2003) 1.94
Allosteric inhibition of protein tyrosine phosphatase 1B. Nat Struct Mol Biol (2004) 1.86
Protein phosphorylation and signal transduction. Pharmacol Ther (1999) 1.79
Crystal structure of the catalytic domain of the human cell cycle control phosphatase, Cdc25A. Cell (1998) 1.66
Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2. Mol Cell (2001) 1.59
Visualization of intermediate and transition-state structures in protein-tyrosine phosphatase catalysis. Proc Natl Acad Sci U S A (1996) 1.57
Solution structure of the MAPK phosphatase PAC-1 catalytic domain. Insights into substrate-induced enzymatic activation of MKP. Structure (2003) 1.54
Active site labeling of the Yersinia protein tyrosine phosphatase: the determination of the pKa of the active site cysteine and the function of the conserved histidine 402. Biochemistry (1993) 1.53
Dimerization inhibits the activity of receptor-like protein-tyrosine phosphatase-alpha. Nature (1999) 1.47
Crystal structure of a phosphoinositide phosphatase, MTMR2: insights into myotubular myopathy and Charcot-Marie-Tooth syndrome. Mol Cell (2003) 1.46
Solution structure of ERK2 binding domain of MAPK phosphatase MKP-3: structural insights into MKP-3 activation by ERK2. Mol Cell (2001) 1.42
Structural genomics of protein phosphatases. J Struct Funct Genomics (2007) 1.40
Dephosphorylation of the C-terminal tyrosyl residue of the DNA damage-related histone H2A.X is mediated by the protein phosphatase eyes absent. J Biol Chem (2009) 1.38
Molecular basis for substrate recognition by MTMR2, a myotubularin family phosphoinositide phosphatase. Proc Natl Acad Sci U S A (2006) 1.30
Crystal structure of the tandem phosphatase domains of RPTP LAR. Cell (1999) 1.27
Differential oxidation of protein-tyrosine phosphatases. J Biol Chem (2004) 1.24
Structure and biochemical properties of PRL-1, a phosphatase implicated in cell growth, differentiation, and tumor invasion. Biochemistry (2005) 1.23
Structural insights into molecular function of the metastasis-associated phosphatase PRL-3. J Biol Chem (2004) 1.22
Crystal structure of bovine heart phosphotyrosyl phosphatase at 2.2-A resolution. Biochemistry (1994) 1.19
Trimeric structure of PRL-1 phosphatase reveals an active enzyme conformation and regulation mechanisms. J Mol Biol (2005) 1.10
The human phosphatase interactome: An intricate family portrait. FEBS Lett (2012) 1.04
Protein tyrosine phosphatases, new targets for cancer therapy. Curr Cancer Drug Targets (2006) 1.03
Structure of human PRL-3, the phosphatase associated with cancer metastasis. FEBS Lett (2004) 1.02
Protein tyrosine phosphatases. Front Biosci (2002) 0.99
Crystal structure of the catalytic domain of human DUSP5, a dual specificity MAP kinase protein phosphatase. Proteins (2007) 0.93
Crystal structure of the catalytic domain of human MAP kinase phosphatase 5: structural insight into constitutively active phosphatase. J Mol Biol (2006) 0.93
Crystal structure of ED-Eya2: insight into dual roles as a protein tyrosine phosphatase and a transcription factor. FASEB J (2009) 0.88
The catalytic mechanism of Cdc25A phosphatase. J Biol Chem (2002) 0.85
PI(3,4,5)P3 regulates the interaction between Akt and B23 in the nucleus. BMB Rep (2010) 0.84
Structure of human dual-specificity phosphatase 27 at 2.38 Å resolution. Acta Crystallogr D Biol Crystallogr (2011) 0.83
Structure of human DSP18, a member of the dual-specificity protein tyrosine phosphatase family. Acta Crystallogr D Biol Crystallogr (2006) 0.82
Crystal structure of human TMDP, a testis-specific dual specificity protein phosphatase: implications for substrate specificity. Proteins (2007) 0.82
Crystal structure of human slingshot phosphatase 2. Proteins (2007) 0.82
Crystal structure of the catalytic domain of human MKP-2 reveals a 24-mer assembly. Proteins (2009) 0.81
Chemical kinomics: a powerful strategy for target deconvolution. BMB Rep (2010) 0.80
Exploring binding sites other than the catalytic core in the crystal structure of the catalytic domain of MKP-4. Acta Crystallogr D Biol Crystallogr (2010) 0.79
Crystal structure of the catalytic domain of human VHY, a dual-specificity protein phosphatase. Proteins (2005) 0.79
Redox regulation of OxyR requires specific disulfide bond formation involving a rapid kinetic reaction path. Nat Struct Mol Biol (2004) 1.99
The diversity of lysine-acetylated proteins in Escherichia coli. J Microbiol Biotechnol (2008) 1.69
Dephosphorylation of the C-terminal tyrosyl residue of the DNA damage-related histone H2A.X is mediated by the protein phosphatase eyes absent. J Biol Chem (2009) 1.38
Structure of human FIH-1 reveals a unique active site pocket and interaction sites for HIF-1 and von Hippel-Lindau. J Biol Chem (2002) 1.34
Synthesis and biological evaluation of rhodanine derivatives as PRL-3 inhibitors. Bioorg Med Chem Lett (2006) 1.19
Trimeric structure of PRL-1 phosphatase reveals an active enzyme conformation and regulation mechanisms. J Mol Biol (2005) 1.10
Crystal structure of DsbDgamma reveals the mechanism of redox potential shift and substrate specificity(1). FEBS Lett (2003) 1.09
Discovery of novel PRL-3 inhibitors based on the structure-based virtual screening. Bioorg Med Chem Lett (2008) 1.01
Structural insight into the constitutive repression function of the nuclear receptor Rev-erbbeta. J Mol Biol (2007) 1.01
NSC-87877, inhibitor of SHP-1/2 PTPs, inhibits dual-specificity phosphatase 26 (DUSP26). Biochem Biophys Res Commun (2009) 0.98
Protein tyrosine phosphatase 1B inhibitors from Morus root bark. Bioorg Med Chem Lett (2005) 0.96
The tetrameric structure of Haemophilus influenza hybrid Prx5 reveals interactions between electron donor and acceptor proteins. J Biol Chem (2003) 0.96
Ganglioside GM3 is involved in neuronal cell death. FASEB J (2006) 0.96
Crystal structure of the catalytic domain of human DUSP5, a dual specificity MAP kinase protein phosphatase. Proteins (2007) 0.93
Crystal structure of the catalytic domain of human MAP kinase phosphatase 5: structural insight into constitutively active phosphatase. J Mol Biol (2006) 0.93
Crystal structure of ED-Eya2: insight into dual roles as a protein tyrosine phosphatase and a transcription factor. FASEB J (2009) 0.88
Sulfamide-based inhibitors for carboxypeptidase A. Novel type transition state analogue inhibitors for zinc proteases. J Med Chem (2002) 0.87
Homophilic interaction of the L1 family of cell adhesion molecules. Exp Mol Med (2012) 0.86
Emodin inhibits migration and invasion of DLD-1 (PRL-3) cells via inhibition of PRL-3 phosphatase activity. Bioorg Med Chem Lett (2011) 0.86
Structural basis of cellular redox regulation by human TRP14. J Biol Chem (2004) 0.84
Structural basis for the cold adaptation of psychrophilic M37 lipase from Photobacterium lipolyticum. Proteins (2008) 0.84
Structure-based virtual screening approach to the discovery of novel PTPMT1 phosphatase inhibitors. Bioorg Med Chem Lett (2011) 0.83
Phosphoproteomic analysis of neuronal cell death by glutamate-induced oxidative stress. Proteomics (2007) 0.83
Crystal structure of human slingshot phosphatase 2. Proteins (2007) 0.82
Broadly neutralizing anti-hepatitis B virus antibody reveals a complementarity determining region H3 lid-opening mechanism. Proc Natl Acad Sci U S A (2007) 0.82
Crystal structure of the major diabetes autoantigen insulinoma-associated protein 2 reveals distinctive immune epitopes. Diabetes (2007) 0.82
Structure of human DSP18, a member of the dual-specificity protein tyrosine phosphatase family. Acta Crystallogr D Biol Crystallogr (2006) 0.82
Crystal structure of human TMDP, a testis-specific dual specificity protein phosphatase: implications for substrate specificity. Proteins (2007) 0.82
Crystal structure of the catalytic domain of human MKP-2 reveals a 24-mer assembly. Proteins (2009) 0.81
Structural mechanism of the antigen recognition by the L1 cell adhesion molecule antibody A10-A3. FEBS Lett (2010) 0.81
Discovery of potent inhibitors of receptor protein tyrosine phosphatase sigma through the structure-based virtual screening. Bioorg Med Chem Lett (2012) 0.81
Enhanced chondrogenic marker expression of human mesenchymal stem cells by interaction with both TGF-β3 and hyaluronic acid. Biotechnol Appl Biochem (2011) 0.81
Structural basis for the dephosphorylating activity of PTPRQ towards phosphatidylinositide substrates. Acta Crystallogr D Biol Crystallogr (2013) 0.81
PTP1B inhibitory effect of abietane diterpenes isolated from Salvia miltiorrhiza. Biol Pharm Bull (2005) 0.80
Crystal structure of the catalytic domain of human VHY, a dual-specificity protein phosphatase. Proteins (2005) 0.79
Biflavonoids inhibited phosphatase of regenerating liver-3 (PRL-3). Nat Prod Res (2006) 0.79
Exploring binding sites other than the catalytic core in the crystal structure of the catalytic domain of MKP-4. Acta Crystallogr D Biol Crystallogr (2010) 0.79
BetaVoid: molecular voids via beta-complexes and Voronoi diagrams. Proteins (2014) 0.78
Discovery of novel Cdc25 phosphatase inhibitors with micromolar activity based on the structure-based virtual screening. J Med Chem (2008) 0.78
Identification of novel inhibitors of mitogen-activated protein kinase phosphatase-1 with structure-based virtual screening. J Comput Aided Mol Des (2011) 0.77
Structure-based de novo design and biochemical evaluation of novel Cdc25 phosphatase inhibitors. Bioorg Med Chem Lett (2009) 0.77
Discovery of VHR phosphatase inhibitors with micromolar activity based on structure-based virtual screening. ChemMedChem (2008) 0.77
Protein tyrosine phosphatase σ in proteoglycan-mediated neural regeneration regulation. Mol Neurobiol (2012) 0.77
Structure-based de novo design of Eya2 phosphatase inhibitors. J Mol Graph Model (2012) 0.77
Broadly neutralizing anti-HBV antibody binds to non-epitope regions of preS1. FEBS Lett (2009) 0.76
Identification of proteins binding to decursinol by chemical proteomics. J Microbiol Biotechnol (2008) 0.76
Crystal structure of constitutively monomeric E. coli Hsp33 mutant with chaperone activity. FEBS Lett (2011) 0.76
Identification of novel inhibitors of extracellular signal-regulated kinase 2 based on the structure-based virtual screening. Bioorg Med Chem Lett (2008) 0.76
Structure of the catalytic domain of protein tyrosine phosphatase sigma in the sulfenic acid form. Mol Cells (2013) 0.75
Identification of potent VHZ phosphatase inhibitors with structure-based virtual screening. J Biomol Screen (2012) 0.75
Purification, crystallization and data collection of the apoptotic nuclease endonuclease G. Acta Crystallogr Sect F Struct Biol Cryst Commun (2009) 0.75
Origin of the stereospecificity in binding hydroxamates of alpha- and beta-phenylalanine methylamide to thermolysin revealed by the X-ray crystallographic study. Bioorg Med Chem (2003) 0.75
Homology modeling and virtual screening approaches to identify potent inhibitors of slingshot phosphatase 1. J Mol Graph Model (2012) 0.75
Proteomic analysis of oxidative stress-induced neuronal cell death by using two-dimensional fluorescence difference gel electrophoresis. Int J Mol Med (2010) 0.75
Crystal structure of a novel mitogen-activated protein kinase phosphatase, SKRP1. Proteins (2011) 0.75